These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11206103)

  • 21. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W; Lopaschuk GD
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calcium antagonists and ischemic heart disease].
    Matsuoka H; Imaizumi T
    Clin Calcium; 2005 Oct; 15(10):1623-30. PubMed ID: 16199907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An old strategy which comes up again: metabolic therapy of acute myocardial infarction].
    Onnis E; Iliceto S
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):667-70. PubMed ID: 12497802
    [No Abstract]   [Full Text] [Related]  

  • 25. Controversies in cardiovascular care: silent myocardial ischemia.
    Hollenberg NK
    Complicat Card Patient; 1987; 1(2):24-30. PubMed ID: 11539715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of uridine and uridine nucleotides on isolated rat heart performance in regional myocardial ischemia].
    Eliseev VV; Rodionova OM; Sapronov NS; Selizarova NO
    Patol Fiziol Eksp Ter; 2002; (2):13-5. PubMed ID: 12152421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases].
    Pogozheva AV; Baĭgarin EK; Derbeneva SA; Varsanovich EA; Miagkova MA
    Vopr Pitan; 2005; 74(4):27-30. PubMed ID: 16265912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic approach to ischemic cardiopathy. Introduction].
    Marzilli M; Ambrosio G
    Ital Heart J; 2004 Mar; 5 Suppl 2():3S. PubMed ID: 15074771
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute myocardial ischaemia induces specific alterations of ventricular mitochondrial function in experimental pigs.
    Zoll J; Ponsot E; Doutreleau S; Mettauer B; Piquard F; Mazzucotelli JP; Diemunsch P; Geny B
    Acta Physiol Scand; 2005 Sep; 185(1):25-32. PubMed ID: 16128694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correction of mineral metabolism impairment with an allowance for seasonal fluctuations in patients with ischemic heart disease and hypertensive disease with overweight].
    Rumiantseva OI; Pogozheva AV; Pokrovskaia GR; Akol'zina SE; Lysikova SL; Aleshko-Ozhevskiĭ IuP; Sheviakova LV; Makhova NO
    Vopr Pitan; 2001; 70(2):25-8. PubMed ID: 11494667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A challenge to the metabolic approach to myocardial ischaemia.
    Apstein CS; Opie LH
    Eur Heart J; 2005 May; 26(10):956-9. PubMed ID: 15797886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormone and phenotypes of cardioprotection.
    Pantos C; Malliopoulou V; Varonos DD; Cokkinos DV
    Basic Res Cardiol; 2004 Mar; 99(2):101-20. PubMed ID: 14963669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteins released from liver after ischaemia induced an elevation of heart resistance against ischaemia-reperfusion injury: 1. Beneficial effect of protein fraction isolated from perfusate after ischaemia and reperfusion of liver.
    Barteková M; Styk J; Pancza D; Kukan M; Seboková J; Breier A
    Gen Physiol Biophys; 2003 Dec; 22(4):567-77. PubMed ID: 15113129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
    Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
    Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary prophylaxis in general practice for patients with ischemic heart disease].
    Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J
    Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of cytokines in pathogenesis of ischaemic heart disease].
    Cecha J; Drabek G; Muc-Wierzgoń M; Romanowski W; Danikiewicz A; Błazelonis A; Zubelewicz-Szkodzińska B
    Pol Arch Med Wewn; 2002 Aug; 108(2):797-800. PubMed ID: 12476900
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammation in ischaemic heart disease.
    Maseri A; Biasucci LM; Liuzzo G
    BMJ; 1996 Apr; 312(7038):1049-50. PubMed ID: 8616394
    [No Abstract]   [Full Text] [Related]  

  • 39. [Synthetic prostacyclins, a new theoretical approach].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(3):490. PubMed ID: 16296475
    [No Abstract]   [Full Text] [Related]  

  • 40. Ischaemic heart disease: clinical improvement with metabolic approach--final remarks.
    Gomes RS
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V41-3. PubMed ID: 11206103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.